Shares of Stryker Drop on Recall News

This morning, Stryker (SYK) said that it’s doing a voluntary recall of “specific lots of Oral Care products sold through the company`s Sage Products business unit.” The problem seems to have come from a third-party provider. Fortunately, Stryker said that it’s not aware of any serious adverse effects.

Earlier Stryker gave full-year guidance of $6.45 to $6.55 per share. Now the company expects to come in at the low end of that range. For Q3, Stryker again expects to be at the low end of the previously announced range of $1.50 to $1.55 per share.

The shares are currently down about 4.5%.

Posted by on August 23rd, 2017 at 2:43 pm


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.